Vögtle F, Richardt G, Werner N. Introduction. In: Vögtle F, Richardt G, Werner N, editors. Dendrimer chemistry: concepts, syntheses, properties, applications. Wiley: Academic; 2009. p. 1–24.
Buhleier E, Wehner W, Vögtle F. “Cascade”- and “nonskid-chain-like” syntheses of molecular cavity topologies. Synthesis. 1978;9:155–8.
Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, et al. A new class of polymers: starburst-dendritic macromolecules. Polym J. 1985;17:117–32.
Tomalia DA, Fréchet JMJ. Discovery of dendrimers and dendritic polymers: a brief historical perspective. J Polym Sci A Polym Chem. 2002;40:2719–28.
Liko F, Hindré F, Fernandez-Megia E. Dendrimers as innovative radiopharmaceuticals in cancer radionanotherapy. Biomacromol. 2016;17:3103–14.
Mintzer MA, Grinstaff MW. Biomedical applications of dendrimers: a tutorial. Chem Soc Rev. 2011;40:173–90.
Rosen BM, Wilson CJ, Wilson DA, Peterca M, Imam MR, Percec V. Dendron-mediated self-assembly, disassembly, and self-organization of complex systems. Chem Rev. 2009;109:6275–540.
Wang D, Astruc D. Dendritic catalysis—basic concepts and recent trends. Coord Chem Rev. 2013;257:2317–34.
Esfand R, Tomalia DA. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov Today. 2001;6:427–36.
Idris AO, Mamba B, Feleni U. Poly (propylene imine) dendrimer: a potential nanomaterial for electrochemical application. Mater Chem Phys. 2020;244: 122641.
Caminade A-M, Majoral J-P. Nanomaterials based on phosphorus dendrimers. Acc Chem Res. 2004;37:341–8.
de Brabander van den Berg EMM, Meijer EW. Poly(propylene imine) dendrimers: large-scale synthesis by hetereogeneously catalyzed hydrogenations. Angew Chem Int Ed Engl. 1993;32:1308–11.
Robert G. Denkewalter, Jaroslav Kolc, Lukasavage WJ. Macromolecular highly branched homogenerous compound based on lysine units. United States Patent, 4,289,872, Sep.15, 1981.
Gillies ER, Fréchet JMJ. Designing macromolecules for therapeutic applications: polyester dendrimer poly(ethylene oxide) “Bow-Tie” hybrids with tunable molecular weight and architecture. J Am Chem Soc. 2002;124:14137–46.
Launay N, Caminade A-M, Lahana R, Majoral J-P. A general synthetic strategy for neutral phosphorus-containing dendrimers. Angew Chem Int Ed Engl. 1994;33:1589–92.
Arseneault M, Wafer C, Morin JF. Recent advances in click chemistry applied to dendrimer synthesis. Molecules. 2015;20:9263–94.
Deng X-X, Du F-S, Li Z-C. Combination of orthogonal ABB and ABC multicomponent reactions toward efficient divergent synthesis of dendrimers with structural diversity. ACS Macro Lett. 2014;3:667–70.
Fan X, Hu Z, Wang G. Facile synthesis of polyester dendrimer via combining thio-bromo “Click” chemistry and ATNRC. J Polym Sci A Polym Chem. 2015;53:1762–8.
Jee J-A, Spagnuolo LA, Rudick JG. Convergent synthesis of dendrimers via the passerini three-component reaction. Org Lett. 2012;14:3292–5.
Tomalia DA, Hedstrand DM, Ferritto MS. Comb-burst dendrimer topology: new macromolecular architecture derived from dendritic grafting. Macromolecules. 1991;24:1435–8.
Abbasi E, Aval SF, Akbarzadeh A, Milani M, Nasrabadi HT, Joo SW, et al. Dendrimers: synthesis, applications, and properties. Nanoscale Res Lett. 2014;9:247.
Shi X, Majoros IJ, Baker JR. Capillary electrophoresis of poly(amidoamine) dendrimers: from simple derivatives to complex multifunctional medical nanodevices. Mol Pharm. 2005;2:278–94.
Bosman AW, Janssen HM, Meijer EW. About dendrimers: structure, physical properties, and applications. Chem Rev. 1999;99:1665–88.
Jackson CL, Chanzy HD, Booy FP, Drake BJ, Tomalia DA, Bauer BJ, Amis EJ. Visualization of dendrimer molecules by transmission electron microscopy (TEM): staining methods and cryo-TEM of vitrified solutions. Macromolecules. 1998;31:6259–65.
Menjoge AR, Kannan RM, Tomalia DA. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today. 2010;15:171–85.
Rao BN, Viswanath V, Reddy KR, Fathima SR, Surekha P, Bhuvaneswari S. Dendrimers–structure, synthesis, encapsulation, characterization and application. J Global Trends Pharm Sci. 2015;6:2860–6.
Parekh HS. The advance of dendrimers–a versatile targeting platform for gene/drug delivery. Curr Pharm Design. 2007;13:2837–50.
Kurtoglu YE, Mishra MK, Kannan S, Kannan RM. Drug release characteristics of PAMAM dendrimer–drug conjugates with different linkers. Int J Pharm. 2010;384:189–94.
Gupta V, Nayak S. Dendrimers: A review on synthetic approaches. J Appl Pharm Sci. 2015;5:117–22.
Liu J, Gray WD, Davis ME, Luo Y. Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review. Interface Focus. 2012;2:307–24.
Yang H, Morris JJ, Lopina ST. Polyethylene glycol–polyamidoamine dendritic micelle as solubility enhancer and the effect of the length of polyethylene glycol arms on the solubility of pyrene in water. J Colloid Interface Sci. 2004;273:148–54.
Pooresmaeil M, Namazi H. Advances in development of the dendrimers having natural saccharides in their structure for efficient and controlled drug delivery applications. Eur Polym J. 2021;148: 110356.
Agrawal P, Gupta U, Jain NK. Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate. Biomaterials. 2007;28:3349–59.
Sharma AK, Gupta L, Sahu H, Qayum A, Singh SK, Nakhate KT, et al. Chitosan engineered PAMAM dendrimers as nanoconstructs for the enhanced anti-cancer potential and improved in vivo brain pharmacokinetics of temozolomide. Pharm Res. 2018;35:9.
Han M, Huang-Fu M-Y, Guo W-W, Guo N-N, Chen J, Liu H-N, et al. MMP-2-Sensitive HA end-conjugated poly(amidoamine) dendrimers via click reaction to enhance drug penetration into solid tumor. ACS Appl Mater Interfaces. 2017;9:42459–70.
Arima H, Motoyama K, Higashi T. Sugar-appended polyamidoamine dendrimer conjugates with cyclodextrins as cell-specific non-viral vectors. Adv Drug Deliv Rev. 2013;65:1204–14.
Agarwal A, Gupta U, Asthana A, Jain NK. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent. Biomaterials. 2009;30:3588–96.
He H, Yuan Q, Bie J, Wallace RL, Yannie PJ, Wang J, et al. Development of mannose functionalized dendrimeric nanoparticles for targeted delivery to macrophages: use of this platform to modulate atherosclerosis. Transl Res. 2018;193:13–30.
Kolhe P, Khandare J, Pillai O, Kannan S, Lieh-Lai M, Kannan RM. Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload. Biomaterials. 2006;27:660–9.
Lancina MG, Wang J, Williamson GS, Yang H. DenTimol as a dendrimeric timolol analogue for glaucoma therapy: synthesis and preliminary efficacy and safety assessment. Mol Pharm. 2018;15:2883–9.
Lancina MG, Yang H. Dendrimers for ocular drug delivery. Can J Chem. 2017;95:897–902.
Wang G, Zhou Z, Zhao Z, Li Q, Wu Y, Yan S, et al. Enzyme-triggered transcytosis of dendrimer–drug conjugate for deep penetration into pancreatic tumors. ACS Nano. 2020;14:4890–904.
Jiang W, Luo X, Wei L, Yuan S, Cai J, Jiang X, et al. The sustainability of energy conversion inhibition for tumor ferroptosis therapy and chemotherapy. Small. 2021;17:2102695.
Liu H, Wang H, Yang W, Cheng Y. Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost. J Am Chem Soc. 2012;134:17680–7.
Shen Y, Zhou Z, Sui M, Tang J, Xu P, Kirk EAV, et al. Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery. Nanomedicine. 2010;5:1205–17.
Pang X, Jiang Y, Xiao Q, Leung AW, Hua H, Xu C. pH-Responsive polymer–drug conjugates: design and progress. J Control Release. 2016;222:116–29.
Wang J, He H, Cooper RC, Gui Q, Yang H. Drug-conjugated dendrimer hydrogel enables sustained drug release via a self-cleaving mechanism. Mol Pharm. 2019;16:1874–80.
Milhem OM, Myles C, McKeown NB, Attwood D, D’Emanuele A. Polyamidoamine Starburst® dendrimers as solubility enhancers. Int J Pharm. 2000;197:239–41.
Dufès C, Uchegbu IF, Schätzlein AG. Dendrimers in gene delivery. Adv Drug Delivery Rev. 2005;57:2177–202.
Eliyahu H, Barenholz Y, Domb AJ. Polymers for DNA delivery. Molecules. 2005;10:34–64.
Surekha B, Kommana NS, Dubey SK, Kumar AVP, Shukla R, Kesharwani P. PAMAM dendrimer as a talented multifunctional biomimetic nanocarrier for cancer diagnosis and therapy. Colloids Surface B. 2021;204: 111837.
Choi YJ, Kang SJ, Kim YJ, Lim YB, Chung HW. Comparative studies on the genotoxicity and cytotoxicity of polymeric gene carriers polyethylenimine (PEI) and polyamidoamine (PAMAM) dendrimer in Jurkat T-cells. Drug Chem Toxicol. 2010;33:357–66.
Zhang J, Liu D, Zhang M, Sun Y, Zhang X, Guan G, et al. The cellular uptake mechanism, intracellular transportation, and exocytosis of polyamidoamine dendrimers in multidrug-resistant breast cancer cells. Int J Nanomed. 2016;11:3677–90.
Abedi-Gaballu F, Dehghan G, Ghaffari M, Yekta R, Abbaspour-Ravasjani S, Baradaran B, et al. PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy. Appl Mater Today. 2018;12:177–90.
Xu L, Yeudall WA, Yang H. Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery. Acta Biomater. 2017;57:251–61.
Chaplot SP, Rupenthal ID. Dendrimers for gene delivery–a potential approach for ocular therapy? J Pharm Pharmacol. 2013;66:542–56.
Cooper RC, Yang H. Duplex of polyamidoamine dendrimer/custom-designed nuclear-localization sequence peptide for enhanced gene delivery. Bioelectricity. 2020;2:150–7.
留言 (0)